#South Korea #Seoul #biopharmaceuticals #biotechnology #Global Bio Conference

Global Bio Conference 2025: Navigating the Future of Biotechnology

The Global Bio Conference 2025 is currently taking place in Seoul, South Korea, marking its 11th year as a key global platform for the biotechnology sector. Organized by the Ministry of Food and Drug Safety, the conference is themed "Bio, Navigating Infinite Possibilities" and runs from September 3 to 5, 2025, at the Grand InterContinental Seoul Parnas.

This year's event has garnered attention from approximately 5,000 attendees, which includes regulatory authorities, industry leaders, and academic professionals. The conference serves as a vital venue for discussing the latest developments in biopharmaceuticals, evaluating future growth strategies, and enhancing the role of regulators in the biotech ecosystem.

A Comprehensive Program

The agenda for GBC 2025 is diverse and extensive, featuring keynote speeches and special lectures that delve into the rapidly changing landscape of global biopharmaceuticals influenced by breakthrough technologies. Sessions include 17 thematic forums focusing on vital topics such as vaccines, advanced biopharmaceuticals, and specialized areas relevant to the industry.

Prominent speakers include Robert S. Langer from MIT, Yukiko Nakatani from the WHO, and Dennis Slamon from UCLA, presenting their insights into next-generation biotechnologies and regulatory innovations. Alongside academic giants, industry figures such as Kim Dong-joong from Samsung Biologics are sharing perspectives on global trends in biopharmaceutical development.

Highlighted Forums on Day 2

The second day of the conference, September 4, focuses on critical topics in the biotech sector. Forums addressing vaccines and recombinant protein products will explore regulatory trends, including discussions on self-amplifying RNA vaccines and the innovative development of next-gen therapies.

The Regulatory Science Innovation Forum will engage global experts to propose strategies aimed at advancing regulatory science, both in Korea and worldwide. Additionally, sessions will include discussions on patient safety management and a workshop exploring partnerships to bolster national regulatory systems in the Western Pacific.

Final Day Insights and Networking Opportunities

On the final day, September 5, the conference culminates with practical workshops and forums designed to facilitate knowledge exchange among regulatory authorities and industry stakeholders. The Regulatory Workshop will introduce advanced authorization systems from global regulators, alongside a Biopharmaceutical Supply Chain Forum focusing on trends in vaccine supply chains and resilience strategies during crises.

Moreover, the Advanced Biopharmaceuticals Policy and Quality Forum examines quality standards and regulatory compliance in the rapidly evolving field of biopharmaceuticals. Regulatory support agencies will present initiatives to help domestic researchers and enterprises connect with available resources.

In addition, emphasis will be placed on innovative testing methods that prioritize animal welfare, with workshops dedicated to alternatives for biological testing. A mentoring program titled "Mentoring for Bio Youths" aims to inspire the next generation of biotech leaders.

Minister Oh Yu-kyoung expressed hope that the GBC would not only ignite meaningful global dialogue on regulatory practices but also establish Korea as a spearhead in biopharmaceutical advancements. The Food and Drug Safety Ministry anticipates that the conference will bolster Korea's international standing in the biopharmaceutical sector while enhancing the global competitiveness of Korean companies.

As we move forward, the GBC 2025 serves as a critical milestone in the ongoing evolution of biotechnology, paving the way for innovation and global cooperation in addressing the needs of tomorrow's healthcare landscape.